How the FDA Lied About the Safety and Effectiveness of Hydroxychloroquine Versus Covid

Executive Summary

  • Hydroxychloroquine is a drug with effectiveness against covid.
  • The FDA both falsely claimed there is no effectiveness and then added false claims of it being a dangerous drug.


Tax dollars partially pay for the FDA. However, it does not work for the public interest, and instead, pharmaceutical companies can view it as a PR front end. How they function is explained in the following quotation from the book Metabolica.

The USDA is the political arm of the food industry, and the FDA is the political arm of the drug industry. The USDA is supposed to support American agriculture in all its guises and to all its consumers, including you. The FDA is supposed to make sure your food and drugs are safe and effective. Both organizations are supposed to be independent of the industries they regulate, yet they do their bidding. Known as “agency capture,” both have a revolving door policy between government and industry about hiring and lobbying. Furthermore, the heads of both come from the private sector and return to it.

How the FDA Exaggerated the Risks of Hydroxychloroquine

This quote is found on the FDA website.

The FDA is aware of reports of serious heart rhythm problems in patients with COVID-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin and other QT prolonging medicines. We are also aware of increased use of these medicines through outpatient prescriptions.

Therefore, we would like to remind health care professionals and patients of the known risks associated with both hydroxychloroquine and chloroquine. We will continue to investigate risks associated with the use of hydroxychloroquine and chloroquine for COVID-19 and communicate publicly when we have more information.

Notice that the FDA does not link to the VAERS database nor provide any context of the safety risk. The safety issue with hydroxychloroquine is also odd as the drug was approved for malaria — and only when HDX started becoming used for treating covid, for which it obtained an Emergency Use Authorization, did these safety issues arise. This same issue occurred with Ivermectin. Ivermectin developed a track record as one of the world’s safest drugs — until it began being used off-label for covid — and then at that point, both the original drug developer – Merck – and the FDA said they found significant safety issues — but only after over four decades of use, and the drug being prescribed to billions. Before covid, Ivermectin was not considered a controversial drug. It was only after Ivermectin showed benefits against covid, and Ivermectin became a controversial drug.

The FDA Pretends it Can’t Remember Why it Provided Emergency Use Authorization for HDX Versus Covid

When HDQ was approved for covid, no vaccines and no on-patent therapies were competing with HDX, and this meant no lost revenue to the pharma companies. However, as soon as these conditions changed, the pharma companies told the FDA to remove the EUA from HDQ. The FDA dances around why they gave HDQ EUA in the first place in the following quote.

Hydroxychloroquine and chloroquine have not been shown to be safe and effective for treating or preventing COVID-19. They are being studied in clinical trials for COVID-19, and we authorized their temporary use during the COVID-19 pandemic for treatment of the virus in hospitalized patients when clinical trials are not available, or participation is not feasible, through an Emergency Use Authorization (EUA).

HDQ is far more effective against covid and far safer than the vaccines; however, neither the ineffectiveness of the vaccines nor their major safety problems leading to a large number of excess deaths after the rollout of the vaccines globally caused the FDA to re-evaluate the covid vaccines the way the FDA did for HDQ.